News

Researchers have identified 27 proteins that are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms.

Research is advancing optical microscopy, helping to solve challenging problems across many fields of science and engineering including semiconductor wafer inspection, nanoparticle sensing, material characterization, biosensing, virus counting, and microfluidic monitoring.

A team has developed a technology that is more than 30 times more sensitive than current lab-based tests in finding early stage cancer biomarkers in blood.

Researchers in the Department of Biomedical Engineering at Texas A&M University are working on an entirely new way to detect blood clots, especially in pediatric patients.

To protect medical laboratory personnel from infection when testing clinical samples for SARS-CoV-2, most laboratories inactivate the virus before testing. In a recent study, researchers tested several inactivation methodologies to determine if and to what extent they reduce detectable virus in a clinical sample.

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

A new viral diagnostic strategy using reactive polymer-grafted, double-stranded RNAs could serve as a pre-screening tester for a wide range of viruses.

Researchers at the Agricultural University of Athens have developed an innovative portable biosensor for the rapid, ultra-sensitive and scaled-up detection of the SARS-CoV-2 S1 protein.

Findings from a new study show that extracellular vesicles promote malaria parasite adhesion to spleen cells.

A team of researchers has conducted a clinical trial to evaluate different combinations of remote pre- and post-test genetic counseling.